News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
For the quarter ended June 2026, Diamondback Energy (FANG) reported revenue of $5.56 billion, up 51.2% over the same period last year. EPS came in at $6.48, compared to $2.67 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …
Sharemaestro market context Trend signal active 52 weeks +43.9%Diamondback Energy's Midland Basin wells have shown a significant rebound in early 2026, indicating no signs of productivity degradation. This report highlights the Permian Basin's well performance, with E&Ps successfully optimizing drilling operations. The article suggests a positive outlook for oil and gas exploration …
Viper Energy, Inc. reported strong financial and operating results for Q2 2026, including average daily production of 65,077 bo/d and consolidated net income of $331 million. The company announced a 32% increase to its base dividend, raising it to $2.00 per Class A share …
Balefire LLC recently acquired a new 5,400-share position in Diamondback Energy, valued at approximately $949,000, during the second quarter. This comes as Diamondback Energy reported strong second-quarter results, exceeding revenue and EPS expectations, and raised its 2026 production guidance. Analysts maintain a positive outlook …
This article provides an AI-driven analysis of Diamedica Therapeutics Inc. (NASDAQ: DMAC) focusing on price dynamics and execution-aware positioning. It highlights divergent sentiment readings, resistance testing, and an exceptional risk-reward short setup. The report outlines three institutional trading strategies (Position, Momentum Breakout, and Risk …
Stifel has reiterated its Buy rating for Black Diamond Therapeutics (BDTX.US) and maintained its target price at $8. This indicates the firm's continued positive outlook on the company's stock performance.
Diamondback Energy (FANG) reported strong Q2 2026 results, with adjusted EPS of $6.48 significantly beating estimates and revenues rising over 51% year-over-year to $5.6 billion. The company's performance was driven by increased production, higher realized oil prices, and strategic share repurchases. Diamondback also updated …
Diamondback Energy (NASDAQ:FANG) recently reported strong Q2 results, beating analyst forecasts for both revenue and EPS by 12% and 13% respectively. Following these results, analysts have increased their earnings per share predictions for 2026, though the consensus price target remains unchanged. The company is …
Diamondback Energy, Inc. reported strong Q2 2026 results with revenue of $5.56 billion and diluted EPS of $6.65, driven by higher oil prices and increased volume. The company saw oil, NGL, and gas revenues rise to $4.8 billion, with average production surpassing 1.0M BOE/d. …
Diamondback Energy received a Buy rating with a $275 price target from analysts due to strong oil prices and an expected recovery in the gas market. The company plans to increase production by 6-7% in the latter half of 2026 and prioritizes debt reduction, …
DiamondRock Hospitality (DRH) is gaining investor attention following strong Q2 2026 results, including higher revenue, net income, and a 22% dividend increase. The company's stock has shown significant momentum, with a 45.39% year-to-date return. While a popular narrative suggests DRH is 50% undervalued with …
Black Diamond Therapeutics reported a Q2 2026 net loss of $9.9 million, or $0.17 per share, with a six-month net loss of $18.9 million, compared to a net income of $46.0 million in 2025 that included a $70.0 million Servier upfront payment. The company's …
Black Diamond Therapeutics, Inc. reported its second-quarter 2026 financial results, showing no license revenue, a net loss of ($9.91M), and a diluted loss per share of ($0.17). This represents an improvement compared to the prior-year quarter's net loss of ($10.56M) and ($0.19) diluted loss …
Black Diamond Therapeutics Inc (BDTX) has released its earnings summary for the quarter that ended on June 30. The article, sourced from Reuters, provides an overview of the company's financial performance. For detailed information and full access to the report, users are directed to …
Black Diamond Therapeutics reported a narrower Q2 net loss of $9.91 million, down from $10.56 million in the prior year. The operating loss also decreased to $12.06 million due to a 10.16% reduction in total operating expenses. The company's cash and equivalents totaled $110.5 …
Diamondback Energy, Inc., Diamondback E&P LLC, and Endeavor Energy Resources, L.P. have updated their beneficial ownership in Viper Energy, Inc. Class A Common Stock through an amended Schedule 13D filing. This filing details their significant stakes in VNOM and announces a definitive Purchase Agreement …
Diamondback Energy Inc. (FANG) shares fell by 2.97% to $186.17 on Wednesday, marking its third consecutive day of losses. Despite this decline, the stock still outperformed the broader market, which saw the Dow Jones Industrial Average rise and the S&P 500 Index fall. The …
Black Diamond Therapeutics reported its Q2 2026 financial results, highlighting positive Phase 2 clinical trial results for silevertinib in non-classical EGFRm NSCLC patients. The company presented data showing strong clinical activity, durable responses, and significant brain penetration, with no new safety signals observed. Black …
Susquehanna has increased its price target for Diamondback Energy (FANG) to $265, up from the previous target of $255. The firm maintains a Positive rating on the stock. This adjustment reflects Susquehanna's updated outlook for the energy company.
Diamondback Energy, Inc. (FANG) discussed its Q2 2026 earnings, highlighting a strategy focused on growth, debt reduction, and capital efficiency. The company raised its 2026 oil and total production guidance without increasing capital expenditure, while also emphasizing inventory replenishment, selective stock buybacks, and the …
Black Diamond Therapeutics, Inc. (BDTX) reported a second-quarter loss of $9.9 million, or 17 cents per share, which surpassed Wall Street expectations of an 18-cent loss. The company's shares were trading at $1.79 on Wednesday, down from $2.73 a year ago. The results were …
Truist Securities has raised its target price for Diamondback Energy, Inc. (FANG.O) to $224 from $220. This adjustment reflects a change in the analyst's valuation of the energy company's stock. The news was reported by Reuters on August 5, 2026.
Diamondback Energy's Director Charles Alvin Meloy sold 33,333 shares of NASDAQ:FANG stock for approximately $6.61 million, reducing his direct holdings by 3.91%. This transaction was part of a pre-arranged Rule 10b5-1 trading plan. The company recently reported strong quarterly earnings, exceeding analyst expectations for …
Diamondback Energy Inc. (FANG) stock fell 3.46% on Tuesday, closing at $191.87. This underperformance occurred despite a strong overall market, with both the S&P 500 Index and the Dow Jones Industrial Average seeing significant gains. This marks the second consecutive day of losses for …
Search by ticker symbol or company name and select a result to open its chart.